Wisconsin Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 10 (62% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 1,676
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 77.91%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 203
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 70.68%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 19.69% 27.59%
White, Hispanic/Latino Patients 55.31% 55.67%
Black/African American, Non-Hispanic/Latino Patients 7.58% 6.90%
Black/African American, Hispanic/Latino Patients 0.72% 0.00%
Asian Patients3 0.89% 0.49%
American Indian/Alaska Native Patients3 0.78% 0.49%
Native Hawaiian/Other Pacific Islander Patients3 0.24% 0.00%
Patients with More than one race3 1.07% 0.49%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.86% 2.46%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.30% 0.49%
Unreported/Refused to Report Race and Ethnicity 10.56% 5.42%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 512
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 73.71%
COVID-19 Immunization Series Completed 616
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 70.20%
COVID-19 Immunization Series Additional 615
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 46.23%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 25.78% 28.73% 46.34%
White, Hispanic/Latino Patients 50.78% 51.46% 15.45%
Black/African American, Non-Hispanic/Latino Patients 10.55% 8.60% 11.87%
Black/African American, Hispanic/Latino Patients 0.78% 0.32% 0.33%
Asian Patients3 1.76% 1.46% 0.81%
American Indian/Alaska Native Patients3 0.78% 0.65% 11.38%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.16% 0.00%
Patients with More than one race3 1.37% 1.62% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 6.25% 3.41% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.39% 0.16% 0.65%
Unreported/Refused to Report Race and Ethnicity 1.56% 3.41% 13.17%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 10.00%
1 to 24 Hours 30.00%
More Than 24 Hours 60.00%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 40.00%
Vaccine confidence 30.00%
Vaccine storage capacity 0.00%
Vaccine supply 20.00%
Other 10.00%
None 40.00%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 20.00%
Average Percent of Health Center Visits Conducted Virtually 16.50%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 30.00%
Number of Mobile Van Sites 4
Number of Pop-up Clinics 5
Number of School-Based Vaccination Sites 1

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 10.00%
Refer patients to another organization that provides monoclonal antibody therapies 50.00%
None 40.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 20.00%
Patient awareness/education 10.00%
Staffing capacity 20.00%
Therapy administration/onsite logistics 10.00%
Other 10.00%
None 60.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021